PlainPharmaWatch

CMS Open Payments · Program Year 2024

AmerisourceBergen Drug Corporation

AmerisourceBergen Drug Corporation reported $268.97 across General Payments, Research, and Ownership to 3 physicians and teaching hospitals across 3 transactions.

See the rankings → How this is sourced
$268.97
All-tracks total
3
Transactions
3
Recipients
#1893
of 1,925 companies

AmerisourceBergen Drug Corporation reported $268.97 across all CMS Open Payments tracks (General + Research + Ownership) to 3 physicians and teaching hospitals in Program Year 2024 - ranking #1893 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $268.97, averaging $89.66 per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer amerisourcebergen-drug-corporation AmerisourceBergen Drug Corporation

$268.97 · #1893/1,925 · 0.0% industry · PY2024

  • TOT $268.97
  • RANK #1893
  • SHARE 0.0%
  • TXN 3
  • RCP 3
  • CAT 1
  • GEN $268.97
  • TOP1 76.0%
  • PY 2024

Volume peers

Nearest volume peer: McKesson Specialty Care Distribution, LLC ($271.93)

Materialise USA LLC$273.65McKesson Specialty Care Dist…$271.93AmerisourceBergen Drug Corpo…$268.97PARI Respiratory Equipment, …$262.70Fresenius USA Inc.$256.00
All-tracks payment totals near AmerisourceBergen Drug Corporation (CMS Open Payments PY2024)

AmerisourceBergen Drug Corporation sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

What the Data Shows for AmerisourceBergen Drug Corporation

$268.97: that is what AmerisourceBergen Drug Corporation reported in payments to 3 physicians and teaching hospitals during Program Year 2024, spread across 3 transactions ($89.66 per transaction, $89.66 per recipient). The company sits at rank #1893 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

3 transactions worth $268.97 make "Food and Beverage" the top general-payment category in the 1-category breakdown below, 100.0% of General Payments (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

"Food and Beverage" leads AmerisourceBergen Drug Corporation's 1-category general-payment breakdown at $268.97, 100.0% of the reported total.

How AmerisourceBergen Drug Corporation divides its payments

General-payment categories, ordered by reported total

1. Food and Beverage$268.97
Payment Type Amount Transactions
Food and Beverage $268.97 3

Recipient Concentration in General Payments

The five largest recipient relationships account for $268.97 (100.0%) of $268.97 in this company's General Payments records across 3 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for AmerisourceBergen Drug Corporation

The five named recipients with the highest reported General Payments from this company

Luis Campos$204.46Stephanie Gill$32.26Cody Griffin$32.25
  1. 1

    Luis Campos

    $204.46 across 1 reported transactions

  2. 2

    Stephanie Gill

    $32.26 across 1 reported transactions

  3. 3

    Cody Griffin

    $32.25 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as AmerisourceBergen Drug Corporation's, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about AmerisourceBergen Drug Corporation.

Carestream Health, Inc.

HHI 6080

Quest Medical Inc.

HHI 6093

Southern Spine, LLC

HHI 6122

Spinal Surgical Strategies, Inc.

HHI 6125

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with AmerisourceBergen Drug Corporation.

Showing 6 of 1,924 companies with CMS-reported payment data.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download AmerisourceBergen Drug Corporation's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.